JiYu Raises $6.5M to Scale Science-Backed K-Beauty in North America, Eyes $70M Revenue by 2026

Table of Contents

1. Key Highlights
2. Introduction
3. A $6.5M Inflection Point: Where the capital goes and why it matters
4. Korea-first development: Manufacturing, sourcing, and technical access
5. Product focus: Toner pads, NAD+ moisturizing cream, and bioactive pipelines
6. Clinical substantiation: What JiYu plans and why it matters
7. NAD+ in topical skincare: science, limits, and the promise
8. Distribution strategy: Amazon, TikTok Shop, and brand-controlled channels
9. Fighting fakes: authenticity, monitoring, and consumer protection
10. Market context: K-beauty’s next phase in North America
11. Regulatory and compliance considerations
12. Operational scaling: supply chain, margin management, and customer retention
13. Risks and challenges ahead
14. What consumers should scrutinize: evidence, transparency, and purchase channels
15. Strategic implications for the beauty industry
16. Outlook: what success looks like and next milestones
17. FAQ

Key Highlights

• JiYu secured $6.5 million in growth capital to accelerate U.S. and North American expansion, prioritize formal clinical studies, and deepen product development rooted in Korean manufacturing.
• The brand projects more than $70 million in annual revenue by 2026 and is positioning clinical substantiation, ingredient transparency, and controlled distribution (official website, Amazon, TikTok Shop) as core differentiators.

Introduction

JiYu is betting that the next phase of global K-beauty will be driven less by trend cycles and more by verifiable science. The Seoul-founded skincare company closed a $6.5 million growth round that it says will bankroll U.S. expansion, larger clinical programs, and an expanded pipeline of formulations built around Korean bioactives and evidence-based results. With a Korea-first development model—formulations developed and produced in South Korea and a commercial strategy led from the United States—JiYu aims to bridge advanced manufacturing expertise with Western customer expectations for transparency and measurable outcomes.

The company’s stated target—more than $70 million in annual revenue by 2026—reflects ambitious scaling. That projection and the capital raise put JiYu squarely in the middle of several converging dynamics shaping beauty today: the internationalization of Korean product innovation; rising consumer demand for substantiated claims; and the increasing importance of omnichannel e-commerce, including marketplaces such as Amazon and new direct-sales environments like TikTok Shop. How JiYu converts its research-first positioning, manufacturing partnerships, and distribution approach into durable growth will matter for the brand and offer lessons for the broader industry.

A $6.5M Inflection Point: Where the capital goes and why it matters

The headline number—$6.5 million—reflects growth-stage funding intended to accelerate commercial expansion rather than early product development. JiYu cited three primary allocations for the proceeds: formal clinical research, expanded product development, and stronger distribution across priority channels. Each allocation targets a distinct bottleneck that has limited many direct-to-consumer (D2C) beauty brands as they move from nascent popularity to scale.

Clinical research A sizable portion of the capital will underwrite independent, peer-reviewed clinical studies that validate product performance. Clinical evidence serves two purposes: it strengthens marketing claims and reduces regulatory and reputational risk associated with unsubstantiated claims. For a brand that frames itself as “science-backed,” clinical data is also a competitive moat; few D2C brands invest in formal trials that meet the methodological standards of peer-reviewed journals.

Product development and pipeline expansion JiYu intends to broaden its portfolio with additional formulations that feature bioactive Korean ingredients. Funding will support research and development activities, including formulation optimization, ingredient sourcing, and stability testing. The brand’s Korea-first development model gives it access to high-performance actives and manufacturing capabilities that many Western brands lack.

Distribution and go-to-market JiYu plans to strengthen its presence on Amazon and TikTok Shop while continuing direct-to-consumer sales on its own platform. Investments will likely target marketing, supply chain scaling, and channel management. These two marketplaces play different but complementary roles: Amazon serves as a high-intent purchase channel with broad reach and logistics infrastructure; TikTok Shop offers discovery and conversion through social content and short-form video commerce.

The company described participation in the funding round from private investors and strategic partners within the beauty industry, a mix that signals both capital and potential distribution or technical collaborations. Investor partners from the industry can accelerate introductions to retail buyers, co-development opportunities, and operational expertise that raw capital alone does not provide.

Korea-first development: Manufacturing, sourcing, and technical access

JiYu’s operational model runs development and production in South Korea while executing commercial strategy from U.S. offices in Miami and Denver. That structural choice has several practical advantages.

Access to advanced manufacturers South Korea is home to a dense ecosystem of cosmetic manufacturers with experience producing high-efficacy formulations at scale. Many Korean manufacturing partners have deep expertise in producing emulsions, encapsulation technologies, peptides, and innovative delivery systems. Working closely with these manufacturers enables brands to iterate formulations more rapidly and to access new actives as they enter the market.

Ingredient quality and novel bioactives JiYu emphasizes a refusal to compromise on ingredient quality and claims that each active compound was chosen because “the science supports it.” Korea’s ingredient pipeline includes both traditional botanicals and modern actives. By sourcing and formulating in Korea, JiYu can leverage concentrated supply chains for certain ingredients and access manufacturers already validated for those actives.

Speed-to-market and iterative development A Korea-centered development approach supports quick iteration cycles. Manufacturers in Seoul often work with multiple global brands and can move from lab batch to pilot production efficiently. For brands that pursue regular product drops and line extensions, that agility reduces time-to-market.

Quality control and standards Producing formulations in Korea does not automatically guarantee superior quality, but it can simplify access to facilities with Good Manufacturing Practice (GMP) and ISO-compliant processes. For a brand prioritizing clinical studies, consistent manufacturing is essential; variability in raw materials or batching undermines trial reproducibility and regulatory scrutiny. JiYu’s emphasis on working with “world-class Korean manufacturers” signals a focus on reproducibility and traceability.

Product focus: Toner pads, NAD+ moisturizing cream, and bioactive pipelines

JiYu’s product portfolio demonstrates a balance between consumer-friendly delivery formats and newer biological targets. Two leading products provide insight into the brand’s technical and market approach.

Renewal & Rejuvenation Toner Pads Toner pads are a highly accessible product format that drives repeat purchasing. JiYu’s flagship pads combine exfoliants and actives to address uneven tone, dark spots, fine lines, and barrier health. The convenience of a pad format makes it easy for consumers to adopt and integrate into routines, while the inclusion of multiple actives positions the product as multifunctional.

The pad format also lends itself to controlled dosing in clinical settings, which simplifies efficacy measurements. Outcomes such as improvements in pigmentation, texture, and transepidermal water loss (TEWL) are measurable and can be quantified through instrument-based endpoints.

NAD+-powered anti-aging moisturizer JiYu’s anti-aging cream targets cellular energy metabolism by incorporating NAD+ as a key active. Nicotinamide adenine dinucleotide (NAD+) plays a central role in mitochondrial activity and cellular repair mechanisms. In theory, topical strategies that influence NAD+ pathways may affect markers of aging such as collagen synthesis and cellular turnover.

The choice to center an anti-aging product on NAD+ is notable because it aligns the brand with more mechanistic, biology-rooted claims rather than surface-level claims. Topically delivered NAD+ or its precursors faces hurdles—skin penetration, stability, and local bioavailability are challenging—but a carefully formulated product, combined with clinical validation, can demonstrate whether meaningful benefits occur.

Pipeline built on bioactive Korean ingredients Beyond these two products, JiYu is expanding formulas that leverage bioactive Korean ingredients and evidence-based results. That combination—heritage ingredients informed by scientific validation—fits a broader market trend where consumers seek authenticity and measurable performance.

Clinical substantiation: What JiYu plans and why it matters

JiYu’s allocation of capital to formal clinical studies is a defining element of its strategy. Clinical trials elevate a brand’s credibility and can unlock marketing narratives that are both persuasive and defensible.

Types of studies that will carry weight Not all studies are equal. For consumer perception and scientific rigor, randomized controlled trials (RCTs), split-face controlled studies, and objective instrument-based trials carry the most weight. Key endpoints that clinical teams often target include:

• Quantitative measures of pigmentation (colorimetry)
• Epidermal barrier function (TEWL)
• Collagen density or dermal thickness (high-frequency ultrasound or confocal imaging)
• Wrinkle depth and skin topography (profilometry)
• Biomarkers from biopsies or noninvasive sampling (where ethically justified)
• Subjective outcomes via validated questionnaires

Peer review and publication JiYu’s stated intent to generate independent, peer-reviewed data differentiates formal studies from in-house consumer panels. Peer-reviewed publications require rigorous methodology, reproducible data, and transparent reporting. The publication process provides third-party validation that can be cited in corporate materials and enhances credibility among medical professionals and informed consumers.

Regulatory impact In the United States, the Food and Drug Administration (FDA) regulates cosmetics and drugs differently. Cosmetics do not require pre-market approval, but claims that imply disease treatment or significant physiological change can trigger drug regulatory oversight. Clinical studies provide evidence to support more specific efficacy claims while helping to avoid classification as a drug. Robust clinical data also helps brands withstand regulatory scrutiny and third-party challenges.

Marketing and distribution leverage Clinical data allows JiYu to pursue distinct marketing angles: evidence-backed messaging, professional endorsements, and placements in channels that rely on clinical credibility—dermatology clinics, medical spas, and professional retail. Clinical substantiation can also facilitate partnerships with platforms and retailers that vet claims more strictly.

NAD+ in topical skincare: science, limits, and the promise

JiYu’s NAD+-focused moisturizer reflects a broader interest in targeting cellular metabolism in skincare. Understanding the scientific context clarifies what clinical studies must show for such products to be credible.

Biological role of NAD+ NAD+ is a coenzyme involved in redox reactions, mitochondrial function, and as a substrate for enzymes that regulate aging, including sirtuins and poly(ADP-ribose) polymerases (PARPs). Cellular NAD+ levels decline with age, and research in model systems links NAD+ pathways to processes associated with aging.

Topical vs. systemic NAD+ strategies Much of the literature on NAD+ and aging comes from systemic interventions in animal models or human supplements that use NAD+ precursors such as nicotinamide riboside (NR) or nicotinamide mononucleotide (NMN). Topical delivery presents additional challenges: the skin’s barrier limits penetration, and molecular stability of NAD+ or its precursors can be an issue in formulation.

Evidence to date Clinical evidence for topical NAD+ remains limited compared with well-studied actives such as retinoids, vitamin C, and niacinamide. Some early-stage human studies and preclinical work suggest potential benefits related to mitochondrial function and markers of cellular stress. Demonstrating clinically meaningful improvements in firmness, collagen density, or wrinkle depth would provide significant validation for a topical NAD+ approach.

Formulation challenges Key formulation considerations include protecting NAD+ from degradation, enhancing skin penetration (via encapsulation or delivery systems), and ensuring local bioavailability at cellular targets. Manufacturers and formulators will need to optimize pH, excipients, and delivery vehicles to preserve activity.

Clinical validation requirements For the NAD+ moisturizer to substantiate its claims, JiYu’s trials should specify endpoints tied to the product’s proposed mechanism: collagen production measures, dermal thickness, or molecular markers of cellular energy could all be relevant. Ideally, results would include both objective instrument-based data and clinically meaningful photographic or biopsy evidence.

Distribution strategy: Amazon, TikTok Shop, and brand-controlled channels

JiYu’s stated distribution channels—official website, Amazon, and TikTok Shop—reflect a hybrid strategy that leverages both owned and partner platforms. Each channel has unique strengths and operational constraints.

Amazon: scale and operational efficiency Amazon provides logistical reach, fulfillment capabilities, and a high-intent buyer base. For skincare brands, Amazon can drive volume, support subscription programs, and handle heavy SKU mix. But Amazon’s marketplace environment also has challenges: price competition, marketplace fees, and the risk of unauthorized resellers.

TikTok Shop: discovery-driven commerce TikTok Shop offers discovery and immediate conversion powered by short-form video. Beauty brands that pair engaging content with fast checkout can see rapid growth. Marketing on TikTok requires creative content tailored to the platform’s trends and algorithms. Success on TikTok is highly dependent on cultural resonance, influencer partnerships, and nimble creative operations.

Direct-to-consumer (D2C): data and margin control Selling through its own site gives JiYu direct customer relationships, richer first-party data, and higher margins. D2C enables subscription models, personalized communications, and owned customer lifecycle management. It also requires investment in retention strategies, customer service, and marketing to drive acquisition.

Channel mix and brand control JiYu’s choice to sell exclusively through official channels indicates a strategy to reduce counterfeiting and unauthorized resale while preserving pricing and brand integrity. Selling on multiple platforms requires consistent inventory controls, channel-specific pricing strategies, and close monitoring to avoid channel conflict.

Fighting fakes: authenticity, monitoring, and consumer protection

Counterfeit products and unauthorized sellers pose both safety and reputational risks for beauty brands. JiYu indicated active monitoring of unauthorized sellers and counterfeit listings.

Authentication strategies Brands deploy a range of tools to combat counterfeits: serialization, tamper-evident packaging, QR codes linked to authentication services, holograms, and supply-chain traceability systems. Some companies use blockchain or centralized verification platforms to provide immutable records of provenance.

Marketplace enforcement On Amazon and other marketplaces, brands can register intellectual property and use tools like Amazon Brand Registry to remove suspected counterfeits. Brand Registry improves the ability to enforce content and listing accuracy but requires active monitoring and legal follow-through.

Customer education Brands can reduce counterfeit exposure by educating consumers about authorized purchase channels, packaging cues that indicate authenticity, and the risks of buying from unauthorized sellers. Regular communication—through email, packaging inserts, or social channels—reinforces the message and drives customers to official storefronts.

Legal and cross-border enforcement Counterfeits often originate in jurisdictions where enforcement is difficult. Brands that pursue legal remedies must balance the costs of litigation against the scale of infringement. Strategic partnerships with customs authorities and marketplace platforms can provide higher-leverage enforcement options without full-scale litigation.

Market context: K-beauty’s next phase in North America

K-beauty established an early reputation for innovation, novel formats, and ingredient-driven routines. JiYu’s strategy reflects the sector’s evolution from novelty and trend-driven interest toward performance-driven expectations among informed consumers.

From trends to evidence Earlier waves of K-beauty emphasized ritual, texture, and affordability. A growing segment of consumers now expects demonstrable results and scientific validation. JiYu’s focus on clinical trials speaks to that shift. Brands that pair cultural authenticity with data-backed claims gain traction among both mainstream buyers and professional channels.

Competitive landscape JiYu enters a competitive field that includes legacy Korean brands expanding globally (e.g., Dr. Jart+, Laneige), specialist actives-focused companies (e.g., The Ordinary, Deciem), and other K-beauty companies that emphasize natural or traditional ingredients with modern formulations (e.g., COSRX, By Wishtrend). Differentiation depends on trustworthy claims, consistent product performance, retail presence, and brand storytelling that connects proof points to consumer experience.

Pricing and positioning Science-backed products often command premium price points when paired with verified clinical results. Pricing strategy will need to align with target customer segments and channel economics. Retail margins on Amazon and TikTok Shop vary; direct sales offer highest margin but require investment in acquisition.

Consumer sophistication Today’s beauty consumer is more ingredient-literate and skeptical of marketing claims. Reviews, third-party endorsements, and clinical publications shape purchase decisions. Brands that transparently present ingredient concentrations, mechanisms of action, and clinical outcomes build credibility.

Regulatory and compliance considerations

As JiYu scales, regulatory clarity will be essential. The U.S. regulatory framework treats cosmetics and drugs differently, and claims that imply biological modification risk elevating a cosmetic product into drug territory.

Claim language and evidence standards Marketing language must match the level of evidence. Claims such as “reduces wrinkles” or “improves skin firmness” are common in cosmetics, but suggesting reversal of intrinsic aging or treatment of disease crosses into drug claims. Well-designed clinical trials can substantiate stronger claims, but brands must align messaging with trial endpoints and regulatory constraints.

Safety and adverse event monitoring Scale increases the probability of adverse event reports. A pharmacovigilance-like system adapted for cosmetics—robust adverse event tracking, batch traceability, and rapid response protocols—will become essential. Clinical studies also help identify safety signals and refine usage recommendations.

Labeling and ingredient transparency U.S. labeling requirements mandate ingredient lists and allergen disclosures in certain cases. JiYu’s emphasis on ingredient transparency will require clear, consistent labeling across jurisdictions and channels.

International regulatory variations Selling globally introduces additional regulatory complexity. Claims acceptable in one market may be restricted in another. JiYu’s Korea-produced formulations must comply with both Korean manufacturing standards and destination market regulations.

Operational scaling: supply chain, margin management, and customer retention

Hitting a $70 million ARR target in 2026 requires more than marketing; it demands operational rigor across sourcing, manufacturing, fulfillment, and customer retention.

Supply chain resiliency Access to Korean manufacturers is a strength, but scale introduces new dependencies. Sourcing higher volumes of specific actives can create bottlenecks. JiYu will need contingency plans, multiple supplier relationships, and inventory management systems to maintain service levels across Amazon, TikTok Shop, and D2C channels.

Manufacturing lead times and forecasting Contract manufacturers typically require minimum order quantities and lead times that must be coordinated with demand forecasts. As new products launch, JiYu will need accurate forecasting to avoid stockouts or excess inventory.

Unit economics and advertising efficiency Customer acquisition costs (CAC) on platforms like TikTok can be volatile. To sustain high growth, JiYu must optimize lifetime value (LTV) through retention, repeat purchases, subscriptions, and cross-sell. Clinical evidence can aid retention by increasing perceived efficacy and justifying premium pricing, but customer experience and fulfillment reliability remain critical.

Customer service and returns Scaling customer support and returns logistics will be essential to preserve reputation. Professional-grade skincare often prompts higher customer service expectations, including consultative guidance and responsive warranty or return policies.

Risks and challenges ahead

The business plan is clear, but several risks could impede JiYu’s path.

Clinical results may be mixed Investing in clinical trials is expensive and carries the risk of null or modest outcomes. If the NAD+ moisturizer or other products fail to show meaningful improvements, the marketing narrative could be undermined.

Channel concentration risks Heavy reliance on a few channels—Amazon and TikTok Shop—exposes JiYu to platform policy changes, algorithm shifts, or marketplace competition. Diversifying revenue sources and strengthening D2C loyalty programs can mitigate this risk.

Counterfeits and marketplace enforcement Despite efforts to control distribution, counterfeiters and unauthorized sellers can erode brand value and consumer trust. Sustained enforcement requires operational and legal investment.

Manufacturing and supply constraints Scaling production without disrupting quality is a recurring challenge for brands that rely on contract manufacturers. Ingredient shortages, lead-time extensions, or geopolitical disruptions could affect deliveries.

Competitive responses Established brands may accelerate their own clinical programs, pricing strategies, or marketing spend in response to JiYu’s positioning. JiYu’s ability to sustain differentiation will depend on execution rather than messaging alone.

What consumers should scrutinize: evidence, transparency, and purchase channels

For buyers seeking performance-driven K-beauty, a checklist of factors helps separate marketing from meaningful claims.

Look for independent clinical data Ask whether the brand’s studies are randomized, controlled, and published or under review. Peer-reviewed evidence carries more weight than in-house consumer surveys.

Evaluate ingredient disclosures Brands that list ingredient names and concentrations (where possible) demonstrate transparency. Understanding active concentrations, pH, and formulation context helps assess likely efficacy.

Check manufacturing provenance Products developed and manufactured in facilities that follow GMP or have recognized certifications signal higher manufacturing controls. Korea-based manufacturing is a plus when paired with traceability.

Buy through authorized channels Purchasing from an official website, brand-registered Amazon listings, or documented retail partners reduces counterfeit risk. Check for seller verification and avoid deep-discount third-party listings.

Assess post-purchase support Return policies, customer service responsiveness, and clearly communicated usage instructions are important for complex formulations, especially anti-aging products that may take weeks to show effects.

Strategic implications for the beauty industry

JiYu’s approach—combining Korea-based formulation expertise with clinical substantiation and controlled distribution—reflects a maturing market expectation. Consumers increasingly demand evidence and responsible sourcing; retailers expect stable supply and defensible claims. Brands that bridge cultural authenticity with scientific rigor can command premium positions, but only if they execute at scale.

The move toward formal trials could encourage other beauty brands to invest in research and peer-reviewed studies. That shift will raise the evidentiary bar for claims and possibly reshape marketing norms. It may also influence channel dynamics: retailers and platforms focused on trust and safety may favor brands with clinical backing.

At the same time, JiYu’s trajectory highlights the operational complexity of global scaling—legal, manufacturing, and marketplace enforcement challenges are nontrivial. The company’s success will depend on integrating scientific validation with robust commercial execution.

Outlook: what success looks like and next milestones

JiYu’s immediate milestones likely include:

• Launch and completion of controlled clinical trials for its flagship products, with publication or conference presentations to establish third-party credibility.
• Expanded availability and marketing on Amazon and TikTok Shop, coupled with scaled D2C operations and subscription offerings for repeat items like toner pads.
• Additional product launches featuring Korean bioactives with clear, study-backed endpoints to broaden revenue streams and support the projected $70 million ARR goal.

Success will hinge on reproducible clinical outcomes, disciplined channel management that minimizes unauthorized resale, and operational scaling that preserves product quality and delivery reliability. If JiYu converts clinical investment into published evidence and leverages that credibility into sustainable customer retention across multiple channels, it will set a notable example for performance-driven Korean brands expanding in North America.

FAQ

Q: What exactly did JiYu raise and who participated? A: JiYu raised $6.5 million in growth capital from private investors and strategic partners within the beauty industry. The round is intended to fund clinical research, expanded product development, and distribution growth in the U.S. and North America.

Q: How will JiYu use the new funding? A: The company plans to allocate capital to formal clinical studies for efficacy validation, expand its product pipeline with additional formulations based on Korean bioactives, and strengthen presence across key distribution channels—particularly Amazon and TikTok Shop—while maintaining direct sales via its official website.

Q: What does “Korea-first development model” mean? A: JiYu develops and produces all formulations in South Korea, leveraging the country’s dense manufacturing expertise and ingredient ecosystem, while managing commercial strategy and sales operations from the United States. This model aims to combine technical formulation strengths with Western market execution.

Q: Is topical NAD+ effective for anti-aging? A: NAD+ plays a central role in cellular energy and repair pathways, and declining NAD+ levels are associated with aging. Topical delivery presents formulation challenges—stability, skin penetration, and local bioavailability. Clinical evidence for topical NAD+ is still emerging. JiYu’s planned clinical studies are intended to evaluate whether their formulation delivers measurable benefits such as improved firmness or collagen support.

Q: Why are clinical studies important for skincare brands? A: Formal clinical studies provide objective, reproducible data to support efficacy claims and improve consumer trust. They help differentiate brands in a crowded market, reduce regulatory risk associated with unsupported claims, and enable more credible marketing and professional endorsements.

Q: Where will JiYu products be sold? A: JiYu sells its products through official channels: its own website, Amazon (brand-registered listings), and TikTok Shop. The company actively monitors unauthorized sellers and counterfeit listings to ensure authenticity.

Q: How does JiYu plan to fight counterfeits? A: JiYu monitors marketplaces and unauthorized sellers, leverages official channels, and can deploy authentication measures and enforcement tools such as marketplace brand registry programs. Additional anti-counterfeiting measures may include serialized packaging, QR-code authentication, and customer education about authorized sellers.

Q: Is JiYu likely to meet its $70M revenue target? A: Achieving more than $70 million in annual revenue by 2026 will require substantial, sustained growth driven by product adoption, retention, and channel expansion. Factors influencing the outcome include clinical trial results, operational scalability, marketing efficiency, and competitive dynamics. The funding, partnerships, and Korea-first manufacturing access provide foundational advantages, but execution across many functions will determine whether the target is met.

Q: How should consumers evaluate JiYu’s claims? A: Look for independent, peer-reviewed clinical evidence, transparent ingredient disclosures, and clear guidance on usage. Purchase from authorized channels to ensure authenticity. Consider product formats that match usage preferences and assess post-purchase support, return policies, and documented trial results where available.

Q: What does JiYu’s strategy mean for the beauty industry? A: JiYu reflects a trend toward performance-based K-beauty that pairs cultural authenticity with rigorous evidence. If successful, the company may influence other brands to invest in clinical validation, tighten distribution controls to protect brand integrity, and elevate standards for substantiated marketing in the D2C and marketplace-driven beauty sectors.